An orally active anti‐apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease
Authors:
Open Access
- 1 October 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 131 (4) , 721-728
Abstract
Apoptosis and mitochondrial dysfunction are thought to be involved in the aetiology of neurodegenerative diseases. We have tested an orally active anti‐apoptotic molecule (CGP 3466B) that binds to glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH) in an animal model with motoneuron degeneration, i.e. a mouse mutant with progressive motor neuronopathy (pmn). In pmn/pmn mice, CGP 3466B was administered orally (10–100 nmol kg−1) at the onset of the clinical symptoms (2 weeks after birth). CGP 3466B slowed disease progression as determined by a 57% increase in life‐span, preservation of body weight and motor performance. This improvement was accompanied by a decreased loss of motoneurons and motoneuron fibres as well as an increase in retrograde transport. Electron microscopic analysis showed that CGP 3466B protects mitochondria which appear to be selectively disrupted in the motoneurons of pmn/pmn mice. The data support evaluation of CGP 3466B as a potential treatment for motor neuron disease. British Journal of Pharmacology (2000) 131, 721–728; doi:10.1038/sj.bjp.0703633Keywords
This publication has 39 references indexed in Scilit:
- Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase: a putative mechanism of degenerationBrain Research Reviews, 1999
- The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouseBritish Journal of Pharmacology, 1998
- Apoptosis, Excitotoxicity, and NeuropathologyExperimental Cell Research, 1998
- Clinical and molecular aspects of motoneurone diseases: animal models, neurotrophic factors and Bcl-2 oncoproteinTrends in Pharmacological Sciences, 1997
- ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing InclusionsNeuron, 1997
- Mitochondria, free radicals, and neurodegenerationCurrent Opinion in Neurobiology, 1996
- Therapeutic horizons for amyotrophic lateral sclerosisCurrent Opinion in Neurobiology, 1996
- The Mouse Mutation Progressive Motor Neuronopathy (pmn) Maps to Chromosome 13Genomics, 1995
- Polymer Encapsulated Cell Lines Genetically Engineered to Release Ciliary Neurotrophic Factor Can Slow Down Progressive Motor Neuronopathy in the MouseEuropean Journal of Neuroscience, 1995
- (—)Deprenyl Increases the Life Span as Well as Activities of Superoxide Dismutase and Catalase but Not of Glutathione Peroxidase in Selective Brain Regions in Fischer RatsAnnals of the New York Academy of Sciences, 1994